SOAT1 and COVID-19: Another face of the coin are the molecular pathways activated by COVID-19 (NFkΒ, JACK-STAT and INF-1γ signaling that are often altered by both solid and hematopoietic malignancies and may therefore promote tumor cell proliferation instead of resumption of normal immune responses [73].